PTGS2 and inflammatory bowel disease: The effect of COX-2 in IBD and CRC is mediated by Prostaglandin E2 (PGE2) acting through specific cell surface receptors (EP), which include four subtypes, EP1, EP2, EP3, EP4, among which the first is proposed as a mediator of PGE2 role in colon carcinogenesis [136].